Hanmi Science Business Model
Hanmi Science, as the operating holding company of Hanmi Group, generates stable profits based on three business models: the holding division, healthcare business division, and pharmaceutical wholesale division.
Business Areas
Holding Company Division | Healthcare Business Division | Pharmaceutical Wholesale Division |
|---|---|---|
It independently generates revenue through equity gains from subsidiaries, patent and trademark royalties, and affiliate management. Based on this, it identifies new growth engines at the group level, shares the risks of new drug development, and is dedicated to establishing mid-to-long-term visions. | Divided into the Medical Device Division, Consumer Health Division, and IT Solution Business Division, we are leading the way in continuous innovative product development and market expansion across various sectors, including medical device business, food manufacturing and distribution, beauty care, and pharmaceutical-specialized IT solutions. | Through HMP Mall, our B2B e-commerce platform centered on pharmacies and hospitals, and a nation-wide sales network, we specialize in distributing pharmaceuticals, quasi-drugs, health functional foods, automated dispensing & packaging system (JVM), beverages, and cosmetics. By establishing an integrated online and offline business model, we have positioned ourselves as a comprehensive pharmacy management partner, supplying all necessary items for efficient pharmacy operations. |
Value Chain
Healthcare
Hanmi Science generates its own revenue in four core business areas—food, cosmetics, medical devices, and IT—through healthcare technology innovation, differentiated product development, and proactive market penetration. The healthcare business has established itself as a core foundation that helps Hanmi Science achieve sustainable growth by accumulating unique technological capabilities and business competitiveness, in addition to revenue generated from its group companies, as a business-oriented holding company.
Food
We provide highly reliable products that support consumers' systematic health management, covering the entire process from the planning, development, production, and distribution of general foods, health functional foods, and special nutritional foods. Leveraging our packed beverage production capabilities, with a focus on plant-based beverages and care foods, we are expanding our OEM and ODM businesses and supplying diverse products to the market, thereby contributing to the promotion of healthy dietary habits.
Main Products |
 Whole Soy Milk, Hanmi TenTen Multi Vitamin, Careme, Live Lactobacillus Probiotics+, etc. |
Core Competitiveness |
Whole Soy Milk Patented Method (Patent No. 10-1409967, Method for manufacturing whole soy milk with improved storage stability) |
Key Achievements |
ㆍAchieved 250 million packs in soymilk and beverage sales by 2025 |
Cosmetics
Based on the probiotics research and development capabilities and know-how accumulated since Hanmi Pharm launched its lactobacillus products in 1987, we offer high-quality pharmacy-exclusive cosmetics. Led by the derma cosmetic brand ‘Pro-Calm’, we help everyone easily experience skin soothing solutions through high-functional bio-cosmetics that aid in fundamentally resolving problematic skin issues.
Main Products |
 EGF ACTIVE VITAL CREAM, FUSIMEDI REPAIR CREAM S, RED X CREAM S, MELA WHITENING MOISTURE SERUM, etc. |
Core Competitiveness |
Proprietary Ingredient Complex '3 PROBIOTIC COMPLEX' |
Key Achievements |
ㆍEGF ACTIVE VITAL CREAM, sold out 470,000 units annually by 2025 |
Medical Devices
We sell various types of medical devices, including anti-adhesives, hemostats, skin bonds, bone substitutes, and diagnostic products. We lead the domestic medical device market, spearheaded by ‘Guardix’, an anti-adhesive that prevents organs or nerves from sticking together during surgery. We are actively discovering and introducing innovative surgical treatment materials, expanding our product lineup. Currently, we have established a lineup of 32 types of medical devices, achieving continuous growth.
Main Products |
 Guardix, Acticlot, SurgiGuard, LIQUIBAND, MONOFIX, etc. |
Core Competitiveness |
Strong Partnership |
Key Achievements |
ㆍAnti-adhesive ‘Guardix’ achieved sales of approximately KRW 23.1 billion in 2025, leading domestic market share |
IT
We provide IT solutions that help companies innovate their business and build efficient work systems. We assist with laboratory quality control, smart process management, medication adherence monitoring and management for clinical trial participants, and distribution traceability management, thereby innovating all business processes, including not only general office environments but also clinical trials, manufacturing, quality control, and logistics.
Main Products |
 KEIDAS, QUANTUM, RFID, etc. |
Core Competitiveness |
Compliance with Data Integrity and Completeness Guidelines Providing Client-Optimized Solutions |
Key Achievements |
ㆍEstablishment of IT systems for clients in various industries such as manufacturing, pharmaceutical bio, and automated logistics |